Early Stage Liver Cancer
Hepatocellular carcinoma (HCC) is a common type of liver cancer that originates in the liver cells. Stage I indicates that the cancer is localized and has not spread beyond the liver, making it more treatable.
Hepatocellular Carcinoma: IMA970A and Durvalumab
We are testing a new treatment combination for patients with early-stage liver cancer after standard therapies. This study aims to see if it can improve treatment results.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Oncologia Medica Melanoma Immunoterapia Oncologica e Terapie Innovative
Soccavo, Italy
Sponsor: IRCCS Istituto Nazionale Tumori Fondazione Pascale
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.